Conference

Welcome Letter

Dear Industry Colleagues,

On behalf of IATI and the Steering Committee of MIXiii Health-Tech.IL, we would like to welcome you to join us at MIXiii Health-Tech.IL conference and events to be held on the 9th and 10th November 2022 at the International Convention Center – ICC Jerusalem.

The healthtech industry has been experiencing dramatic changes due to the COVID-19 pandemic. From unique collaborations with players coming outside of the life sciences industry through fast paced adoption of digital health and remote health solutions, the pandemic had a huge impact on the industry. This also led to a record year when it comes to funding in 2021. The healthcare landscape is continuing to shift towards a more integrated ecosystem, converging biopharma, med-tech, digital and healthcare into a single bio-convergent industry. This emerging bio-convergent healthtech space holds great potential to make a transformative impact on health and healthcare practices. When it comes to holding a leading position in this emerging bio-convergent field, Israel has substantial strengths and capabilities.

As the Israel’s Umbrella Organization of the High-Tech & Life Science industries, IATI continuously acts to connect and promote the country’s massive resources of academic and technological prowess towards creating a fertile ecosystem which will nourish growth in the coming years as well.

MIXiii Health-Tech.IL conference will showcase all innovative trends and changes in the industry, and is a unique opportunity for all of us to meet and exchange knowledge, network and evolve our magnificent industry into the future.

Looking forward to seeing you at MIXiii Health-Tech.IL.

Sincerely,

Karin Mayer Rubinstein
Karin Mayer RubinsteinCEO & President Israel Advance Technology Industries (IATI)
Yaacov Michlin
Yaacov MichlinConference Chair & CEO, BioLight Life Sciences Ltd.

MIXiii Health-Tech.IL Steering Committee

Mr. Mati Gill
Mr. Mati GillCEO, AION Labs
Dr. Eran Haray
Dr. Eran HaraySVP, Global Head of Specialty R&D , Teva Pharmaceuticals
Adv. Daphna Murvitz
Adv. Daphna MurvitzCo-Founder and CEO, 8400 The Health Network
Mr. Itzik Ozer
Mr. Itzik OzerSenior Director - Business Director, The Jerusalem Development Authority
Ms. Michal Reisfeld
Ms. Michal Reisfeld Chief Marketing Officer (CMO), Israel Innovation Authority
Prof. Irit Sagi
Prof. Irit SagiVP for Innovation & Technology Transfer, Weizmann Institute of Science
 Mr. Zachi Schnarch
Mr. Zachi Schnarch Chief Technology Officer (CTO), Israel Innovation Authority
Ms. Gila Tolub
Ms. Gila TolubPartner, McKinsey Israel
Uri Yaron, PhD
Uri Yaron, PhDFormer Worldwide President, Biosense Webster, Johnson & Johnson
Dr. Eyal Zimlichman
Dr. Eyal ZimlichmanDeputy Director General, Chief Medical Officer and Chief Innovation Officer, Sheba Medical Center

Conference Main Topics

The conference will expose the latest developments within the healthcare and life science that emphasizes the synergy between bio-technology, engineering, technology and computerized systems.

The speakers at the event will include international top leaders in the Healthcare space coming from Google, AstraZeneca, Amazon, Teva, Amgen, McKinsey, Morgan Stanley, Ovid, Mayo Clinic, Cleveland clinic, Lumenis and more.

The Hospital of the Future – Quality & Efficiency  Advances in Neurosciences Emerging Bio-Convergence Implications and Expediting Healthcare Outcome
Healthcare Shift to: “Out-of-Hospital” Settings Integrated and Innovative Diagnostics and Monitoring The Drugs of Tomorrow